Advertisement

Topics

Ionis Pharma Release: Enrollment In Phase I/IIa Study Of IONIS-HTT Rx In Patients With Huntington's Disease Completed And Open-Label Extension Study To Open In 2H 2017

20:00 EDT 21 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Ionis Pharma Release: Enrollment In Phase I/IIa Study Of IONIS-HTT Rx In Patients With Huntington's Disease Completed And Open-Label Extension Study To Open In 2H 2017

NEXT ARTICLE

More From BioPortfolio on "Ionis Pharma Release: Enrollment In Phase I/IIa Study Of IONIS-HTT Rx In Patients With Huntington's Disease Completed And Open-Label Extension Study To Open In 2H 2017"

Advertisement
Quick Search
Advertisement
Advertisement